SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001308179-21-000277
Filing Date
2021-04-29
Accepted
2021-04-29 16:02:37
Documents
6

Document Format Files

Seq Description Document Type Size
1 ULTRAGENYX PHARMACEUTICAL INC. - DEFA14A lrare2021_defa14a.htm DEFA14A 13046
2 GRAPHIC box1.jpg GRAPHIC 1039
3 GRAPHIC checkbox1.jpg GRAPHIC 1296
4 GRAPHIC notice1.jpg GRAPHIC 361648
5 GRAPHIC notice2.jpg GRAPHIC 181059
6 GRAPHIC ultragenyx_logo.jpg GRAPHIC 19376
  Complete submission text file 0001308179-21-000277.txt   791972
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36276 | Film No.: 21870361
SIC: 2834 Pharmaceutical Preparations